KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Operating Leases (2019 - 2024)

Historic Operating Leases for Novartis Ag (NVS) over the last 8 years, with Q4 2025 value amounting to $1.9 billion.

  • Novartis Ag's Operating Leases rose 418510.64% to $1.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.9 billion, marking a year-over-year increase of 418510.64%. This contributed to the annual value of $1.9 billion for FY2025, which is 418510.64% up from last year.
  • According to the latest figures from Q4 2025, Novartis Ag's Operating Leases is $1.9 billion, which was up 418510.64% from -$1.8 billion recorded in Q1 2025.
  • Novartis Ag's Operating Leases' 5-year high stood at $1.9 billion during Q4 2025, with a 5-year trough of -$2.0 billion in Q1 2022.
  • Over the past 5 years, Novartis Ag's median Operating Leases value was -$47.0 million (recorded in 2024), while the average stood at -$370.4 million.
  • As far as peak fluctuations go, Novartis Ag's Operating Leases crashed by 13219.18% in 2024, and later surged by 418510.64% in 2025.
  • Quarter analysis of 5 years shows Novartis Ag's Operating Leases stood at $1.9 billion in 2021, then crashed by 98.79% to $23.0 million in 2022, then soared by 534.78% to $146.0 million in 2023, then tumbled by 132.19% to -$47.0 million in 2024, then soared by 4185.11% to $1.9 billion in 2025.
  • Its last three reported values are $1.9 billion in Q4 2025, -$1.8 billion for Q1 2025, and -$47.0 million during Q4 2024.